The Leibniz Association is funding the research network “Leibniz Health Technologies” (LGT) with 1.2 million euros until the end of 2024, thus starting the second development phase of new projects in which complementary competencies from 14 Leibniz institutes are combined to develop innovative health technologies.
The member institutes work on specific technology solutions for urgent medical issues and jointly pursue the goal of improving the medical care of patients. Through an interdisciplinary approach, prevention, diagnostics and therapy are to grow together and thus increase the quality of life.
The alliance will research and implement technologies that, for example, improve the molecular diagnosis of chronic respiratory diseases and cancer or enable new forms of plasma medical wound therapy. Similarly, new multimodal imaging methods are to be combined with “machine learning” approaches and bioactive materials will be developed that release targeted active substances.
“The overall goal of Leibniz Health Technologies is to integrate existing and new medical technologies from member institutes into medical workflows. With the new funding, we will expand the application fields of our technologies and develop them further into mature systems”, says network spokesman Prof. Jürgen Popp (Leibniz Institute of Photonic Technology).
„The Leibniz Association offers IHP the opportunity to expand its competencies in the field of microelectronic components for medical applications”, says Prof. Christian Wenger (IHP -Innovations for High Performance Microelectronics).
In the coming months, several new projects will be launched in the five competence fields of the group - “Point-of-Care-Technologies“, “Biomarkers”, “Bioactive Materials”, “Plasma Medicine” and “Imaging Methods” – bringing together the strengths of the 14 participating Leibniz Institutes and the two spin-offs.